Jan. 13, 2022, 6:24 p.m. | Georgi Georgiev

Towards Data Science - Medium towardsdatascience.com

Photo by National Cancer Institute on Unsplash

A full year has passed since results from the first clinical trials of COVID-19 vaccines became available. Vast swaths of follow-up observational data are now in circulation which enables some conclusions about the strengths and weaknesses of those trials. Since modern medical trials are among the most rigorous and scrutinized experiments they can serve as a case study with applications to online experiments with which they share more similarities than may be apparent. …

a-b-testing covid covid-19 data science statistical-analysis statistics vaccine

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Data Management Associate

@ EcoVadis | Ebène, Mauritius

Senior Data Engineer

@ Telstra | Telstra ICC Bengaluru